Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/0036933020941497 http://scihub22266oqcxt.onion/10.1177/0036933020941497 C7345441!7345441 !32638647     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32638647 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Scott+Med+J 2020 ; 65 (3 ): 72-75 Nephropedia Template TP {{tp|p=32638647 |t=2020. Alternative management of Covid-19 infection |pdf=|usr=}}{{32638647 }} gab.com Text Alternative management of Covid-19 infection JO: Scott Med J http://www.kidney.de/pget.php?&tw=1&pmid=32638647 #FOAvip Cytokine storm is a life-threatening complication of Covid-19 infection. Excessive cytokines are the products of hyperactive immune inflammatory response mounted by the host against the virus. There is no agreed treatment for cytokine storm. Three therapeutic agents with proven immune-modulatory properties in regular use in a wide range of inflammatory disorders (high dose intravenous immunoglobulin, Rituximab and thalidomide) are proposed for the treatment of cytokine storm. Safety and efficacy of the proposed treatment should be assessed by randomised controlled clinical trials. The use of the proposed treatment is expected to reduce the mortality rate and alter the overall management of the pandemic. Twit Text FOAVip Alternative management of Covid-19 infection ????Scott Med J http://www.kidney.de/pget.php?&tw=1&pmid=32638647 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32638647 #FOAvip English Wikipedia <ref>{{Cite pmid|32638647 }}</ref> Alternative management of Covid-19 infection #MMPMID32638647 Atrah HI Scott Med J 2020[Aug]; 65 (3 ): 72-75 PMID32638647 show ga Cytokine storm is a life-threatening complication of Covid-19 infection. Excessive cytokines are the products of hyperactive immune inflammatory response mounted by the host against the virus. There is no agreed treatment for cytokine storm. Three therapeutic agents with proven immune-modulatory properties in regular use in a wide range of inflammatory disorders (high dose intravenous immunoglobulin, Rituximab and thalidomide) are proposed for the treatment of cytokine storm. Safety and efficacy of the proposed treatment should be assessed by randomised controlled clinical trials. The use of the proposed treatment is expected to reduce the mortality rate and alter the overall management of the pandemic. |*Betacoronavirus [MESH] |Administration, Intravenous [MESH] |COVID-19 [MESH] |COVID-19 Drug Treatment [MESH] |Coronavirus Infections/complications/*drug therapy [MESH] |Cytokine Release Syndrome/drug therapy/etiology [MESH] |Drug Therapy, Combination/methods [MESH] |Humans [MESH] |Immunoglobulins, Intravenous/administration & dosage/*therapeutic use [MESH] |Immunologic Factors/administration & dosage/*therapeutic use [MESH] |Pandemics [MESH] |Pneumonia, Viral/complications/*drug therapy [MESH] |Rituximab/administration & dosage/*therapeutic use [MESH] |SARS-CoV-2 [MESH]Alternative management of Covid-19 infection (epmc).pdf DeepDyve Pubget Overpricing